On March 17, a ceremony was held grandly at Wuhan Optics Valley for the settlement of key projects of first batch of "Urban Partners" in Wuhan and the launching of Considerin Group's Central China Base, which signified that Considerin Group officially marched into Wuhan and Hubei. The implementation of the project will not only benefit the health management, disease prevention and precision medicine carried out in Wuhan and Hubei based on gene technology, but also boost the development of bio-industry in Wuhan. On that day, the ceremony was attended by more than 200 guests and media friends who together witnessed the opening of a new chapter to the development of Considerin Group.

On December 2, 2016, hosted by the Administration Committee of Pingshan New District of Shenzhen and Chinese Gene Sequencing Technology and Industry Alliance, organized by Shenzhen HYK Gene Technology Co., Ltd., the first "Summit of Chinese Gene Sequencing Technology and Industry Alliance & Opening Ceremony of the Alliance's Base in Shenzhen" was held grandly at Pingshan New District of Shenzhen. The event was attended by more than 250 famous experts and scholars of the industry, governmental leaders, excellent enterprise representatives, senior investment experts and media guests from home and abroad.

On September 22, the most bustling place in the beautiful coastal city Xiamen should be International Convention Center. In the sun of early autumn, the annual academic event of clinical oncology--9th Chinese Society of Clinical Oncology (2016 CSCO) was convened grandly at Xiamen International Convention Center.

Most researches of cancer precision medicine are only confined to the patients that have been included in clinical tests. Few researches evaluate how doctors in daily life use biomarkers to recommend chemotherapy or decide the treatment scheme for the patients. Today, we will talk about a research published on the journal Cancer, which has disclosed how in daily life precision medicine improves the treatment of cancer.

October of each year is the "World's Month for Prevention and Control of Breast Cancer", which is also called "Pink Ribbon Month". Breast cancer is the commonest cancer among women, as well as "No.2 killer" for the death of women, only after lung cancer. To enhance the awareness of the public in breast cancer, various publicity activities will be staged in this period across the world. Earlier, famous architectures such as White House, Tokyo Tower and Burj Dubai have put on a pink outfit in succession to appeal the public to pay more attention to breast cancer.

Recently, with a kind of virus researchers have imported a specific gene into the brain to stop the worsening of senile dementia in small mice. This research was sponsored by Alzheimer's Research UK and European Research Council. Related research results were published on the journal PNAS on October 10.

On October 29, the 76th China International Medical Equipment Fair (CMEF) was held at Shenzhen Convention & Exhibition Center. On the largest medical equipment fair in the Asia-Pacific region, as the globally leading provider of gene sequencing system solutions for precision medicine, HYK has attended the event with its national key new product and nationally initiative clinical high-throughput gene sequencer--HYK-PSTAR-IIA gene sequencing system. It exhibited its achievements accumulated from eight years of innovation based on a theme of "Building a Leading Brand of Gene Sequencer in China".

Recently, co-launched by Thousand Talents, a journal designated by the national "The Thousand Talents Program", Shanghai Oracle Bay and the party committee and government of Bengbu City, the "2015 Conference on Big Data Technology and Industrial Application" was held grandly in Bengbu of Anhui which is reputed as a "City of Pearls". Around 30 experts of the said national " The Thousand Talents Program" from the field of big data were invited to the event, who discussed the application and challenges of big data technology and looked into the trend of combination of big data and industries.

During the two sessions each year, the topic of medical treatment and health always attracts extra attention. At present, "precision medicine" has become a hot word in the industry. Precision medicine comprises diagnosis and treatment, while precise diagnosis is the precondition to precise treatment. As the most advanced detection technology in the field of precise treatment, high-throughput gene sequencing technology can significantly accelerate the gene sequencing and shorten the clinical gene sequencing time to 10 hours. With a preciseness above 99.9%, this technology has greatly stimulated the development of precision medicine. Non-invasive in vitro diagnosis technologies such as liquid biopsy and non-invasive prenatal diagnosis have come into being with the development of high-throughput gene sequencing technology. All of these have become part of the profound connotation of "Healthy China" strategy.